Guido Lancman
9PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz
|Oct 02, 2023
A Landmark Paper That Introduced Proteasome Inhibition in Myeloma.Anup Joseph Devasia, Guido Lancman, A Keith Stewart
|Sep 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.Guido Lancman, Kian Parsa, Krzysztof Kotlarz
|Oct 06, 2022
Trial designs and endpoints for immune therapies in multiple myeloma.Guido Lancman, Erin Moshier, Hearn Jay Cho
|Oct 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and Future.Guido Lancman, Dahniel L Sastow, Hearn J Cho
|Sep 22, 2021
Impact of rituximab on COVID-19 outcomes.Hannah Levavi, Guido Lancman, Janice Gabrilove
Pageof 2
Frequent Collaborators
2 joint publications
Hearn Jay Cho
2 joint publications
Ajai Chari
2 joint publications
Shambavi Richard
2 joint publications
Joshua Richter
2 joint publications
A Keith Stewart
1 joint publications
Hannah Levavi
1 joint publications
Janice Gabrilove
1 joint publications
Kian Parsa
1 joint publications
Krzysztof Kotlarz
1 joint publications
Lisa Avery
